I agree. You're never going to agree with all the decisions that are made, and there is certainly a wide variety of different values that people are going to bring to issues around pharmaceutical policy and what drugs should be covered and what drugs shouldn't.
But I think the more transparency there is and the more you can see how decisions were being made...you may not like them, but you're more likely to accept them. So transparency goes on a number of levels. For instance, I think the CDR should be more open to really seeing the evidence basis for its decisions. I wouldn't have any problem if they had open hearings, the way the FDA does, to allow different groups to make presentations before they make their decision.
I would also like to see some transparency from the pharmaceutical industry around why it's charging the prices it is for the drugs. Why are some things worth $20,000 or $50,000? If they can prove that it's the real value of these things, that's fine. So far, we don't see that either.